159 related articles for article (PubMed ID: 16731861)
1. A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.
Raeder H; Bjørkhaug L; Johansson S; Mangseth K; Sagen JV; Hunting A; Følling I; Johansen O; Bjørgaas M; Paus PN; Søvik O; Molven A; Njølstad PR
Diabetes; 2006 Jun; 55(6):1899-903. PubMed ID: 16731861
[TBL] [Abstract][Full Text] [Related]
2. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes.
Ek J; Hansen SP; Lajer M; Nicot C; Boesgaard TW; Pruhova S; Johansen A; Albrechtsen A; Yderstraede K; Lauenborg J; Parrizas M; Boj SF; Jørgensen T; Borch-Johnsen K; Damm P; Ferrer J; Lebl J; Pedersen O; Hansen T
Diabetes; 2006 Jun; 55(6):1869-73. PubMed ID: 16731855
[TBL] [Abstract][Full Text] [Related]
3. Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes.
Anuradha S; Radha V; Mohan V
Clin Genet; 2011 Dec; 80(6):541-9. PubMed ID: 21062274
[TBL] [Abstract][Full Text] [Related]
4. Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro.
Wirsing A; Johnstone KA; Harries LW; Ellard S; Ryffel GU; Stanik J; Gasperikova D; Klimes I; Murphy R
Diabet Med; 2010 Jun; 27(6):631-5. PubMed ID: 20546279
[TBL] [Abstract][Full Text] [Related]
5. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
[TBL] [Abstract][Full Text] [Related]
6. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes.
Chèvre JC; Hani EH; Boutin P; Vaxillaire M; Blanché H; Vionnet N; Pardini VC; Timsit J; Larger E; Charpentier G; Beckers D; Maes M; Bellanné-Chantelot C; Velho G; Froguel P
Diabetologia; 1998 Sep; 41(9):1017-23. PubMed ID: 9754819
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor-4alpha P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population.
Hara K; Horikoshi M; Kitazato H; Ito C; Noda M; Ohashi J; Froguel P; Tokunaga K; Tobe K; Nagai R; Kadowaki T
Diabetes; 2006 May; 55(5):1260-4. PubMed ID: 16644680
[TBL] [Abstract][Full Text] [Related]
8. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young.
Møller AM; Dalgaard LT; Ambye L; Hansen L; Schmitz O; Hansen T; Pedersen O
J Clin Endocrinol Metab; 1999 Jan; 84(1):367-9. PubMed ID: 9920109
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
Guo S; Lu H
J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoter-driven HNF4A-MODY diabetes.
Kind L; Molnes J; Tjora E; Raasakka A; Myllykoski M; Colclough K; Saint-Martin C; Adelfalk C; Dusatkova P; Pruhova S; Valtonen-André C; Bellanné-Chantelot C; Arnesen T; Kursula P; Njølstad PR
JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855865
[TBL] [Abstract][Full Text] [Related]
11. Rare variants identified in the HNF- 4 alpha beta-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes.
Mitchell SM; Vaxillaire M; Thomas H; Parrizas M; Benmezroua Y; Costa A; Hansen T; Owen KR; Tuomi T; Pirie F; Ryffel GU; Ferrer J; Froguel P; Hattersley AT; Frayling TM
Diabetologia; 2002 Sep; 45(9):1344-8. PubMed ID: 12242469
[TBL] [Abstract][Full Text] [Related]
12. Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function.
Ek J; Grarup N; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
Hum Mutat; 2001 Oct; 18(4):356-7. PubMed ID: 11668623
[TBL] [Abstract][Full Text] [Related]
13. P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans.
Lehman DM; Richardson DK; Jenkinson CP; Hunt KJ; Dyer TD; Leach RJ; Arya R; Abboud HE; Blangero J; Duggirala R; Stern MP
Diabetes; 2007 Feb; 56(2):513-7. PubMed ID: 17259399
[TBL] [Abstract][Full Text] [Related]
14. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians.
Johansson S; Raeder H; Eide SA; Midthjell K; Hveem K; Søvik O; Molven A; Njølstad PR
Diabetes; 2007 Dec; 56(12):3112-7. PubMed ID: 17827402
[TBL] [Abstract][Full Text] [Related]
15. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.
Lehto M; Wipemo C; Ivarsson SA; Lindgren C; Lipsanen-Nyman M; Weng J; Wibell L; Widén E; Tuomi T; Groop L
Diabetologia; 1999 Sep; 42(9):1131-7. PubMed ID: 10447526
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.
Kaci A; Solheim MH; Silgjerd T; Hjaltadottir J; Hornnes LH; Molnes J; Madsen A; Sjøholt G; Bellanné-Chantelot C; Caswell R; Sagen JV; Njølstad PR; Aukrust I; Bjørkhaug L
Hum Mol Genet; 2024 May; 33(10):894-904. PubMed ID: 38433330
[TBL] [Abstract][Full Text] [Related]
17. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young.
Thomas H; Jaschkowitz K; Bulman M; Frayling TM; Mitchell SM; Roosen S; Lingott-Frieg A; Tack CJ; Ellard S; Ryffel GU; Hattersley AT
Hum Mol Genet; 2001 Sep; 10(19):2089-97. PubMed ID: 11590126
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.
Kaisaki PJ; Menzel S; Lindner T; Oda N; Rjasanowski I; Sahm J; Meincke G; Schulze J; Schmechel H; Petzold C; Ledermann HM; Sachse G; Boriraj VV; Menzel R; Kerner W; Turner RC; Yamagata K; Bell GI
Diabetes; 1997 Mar; 46(3):528-35. PubMed ID: 9032114
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
[TBL] [Abstract][Full Text] [Related]
20. Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies.
Barroso I; Luan J; Wheeler E; Whittaker P; Wasson J; Zeggini E; Weedon MN; Hunt S; Venkatesh R; Frayling TM; Delgado M; Neuman RJ; Zhao J; Sherva R; Glaser B; Walker M; Hitman G; McCarthy MI; Hattersley AT; Permutt MA; Wareham NJ; Deloukas P
Diabetes; 2008 Nov; 57(11):3161-5. PubMed ID: 18728231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
